Description: Presented at October 1985 Annual Meeting. Discusses the outlook for U.S. government statistics after budget costs and restraints, statistics of income, outlook for linked studies among the different agencies, plans for a 1987 National Medical Expenditures Survey, and the use of government statistics in marketing studies.

Description: Focus on how innovative health care organizations develop their value proposition for their intended buyers. Presenters will share information about their specific solution and the methods used to derive credible savings estimates, ROI, and performance guarantees. Learn about data utilized, the methods deployed, advantages, disadvantages, and buyers' reaction. This session is expected to be technical, highly informative, and interactive with audience members.

Description: Complete listing of the tables used in the study to analyze the research data. From Group Medical Insurance Large Claims Database Collection and Analysis, M-HB97-1.

Description: Chapter 1 presents the background to the current study, followed by the methodology used, and a summary of the findings of the study. From Group Medical Insurance Large Claims Database Collection and Analysis, M-HB97-1.

Description: In late 2021, U.S. Congress passed the Consolidated Appropriations Act (CCA), which requires group health plans and health insurers to submit information regarding the costs of prescription drug costs and other health care services each year to the federal government. Learn how this data can be useful to anyone responsible for forecasting and budgeting.

Description: The time has arrived for ASU 2018-12, otherwise known as Long-Duration Targeted Improvements (LDTI). For health insurance products, the ASU will require considerable efforts to make the necessary changes to valuation systems, procedures, assumptions, and/or methodologies in order to be in compliance. This session is designed to cover LDTI implications specific to carriers of long-term care and supplemental health products, including changes to how attained age rated products will be approached, allocating and discounting the claim liability (IBNR), and how the treatment of Profits Followed by Losses (PFBL) will evolve under LDTI. By attending this session, you will be able to: • Understand LDTI’s key impacts on long-duration health insurance products. • Recognize the treatment of attained age rated products under LDTI. • Comprehend the requirements of allocating the claim liability to cohorts. • Grasp the requirements pertaining to the discounting of the claim liability. • Understand how PFBL will evolve under the new standard.

Description: The South African life insurance industry contains the largest life insurance market in Africa, it is highly sophisticated and highly regulated. In the years 2020 and2021, the industry suffered significant mortality losses due toCovid-19. What can we learn from this experience in South Africa?

Description: Chapter 6 analyzes, in table form, the study's hospital and non-hospital charges and claimant counts in relation to deductible and broken down by plan design type. From Group Medical Insurance Large Claims Database Collection and Analysis, M-HB97-1.

Description: Chapter 3 analyzes, in table form, the study's claimant counts and charge totals, broken down by plan design type, gender, age, year, and by subscriber vs. dependent. From Group Medical Insurance Large Claims Database Collection and Analysis, M-HB97-1.

Description: Chapter 7 analyzes, in table form, the study's claimant counts & charges per claimant in relation to deductible and broken down by diagnosis category. From Group Medical Insurance Large Claims Database Collection and Analysis, M-HB97-1.